First AD

Second AD

Personalizing Therapy in Myelofibrosis: Insights from Key Clinical Trials

Video content above is prompted by the following:

Dr Kuykendall to faculty: Based on the current data, how do you select personalized therapy for patients with MF?

Video Series

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

ASH 2024: Polycythemia Vera and Myelofibrosis: Current and Future Standards of Care  

Peer Exchange

Panelists discuss how they select personalized therapy for patients with myelofibrosis (MF) based on current data, considering factors such as disease characteristics and patient-specific factors.